Medline (MDLN) Accounts Payables (2024 - 2026)

Medline (MDLN) has 3 years of Accounts Payables data on file, last reported at $932.0 million in Q1 2026.

• Quarterly Accounts Payables changed N/A year-over-year to $932.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $932.0 million (changed N/A YoY) and the FY2025 annual result came in at $961.0 million, up 10.59% from the prior year.
• Accounts Payables eased to $932.0 million in Q1 2026 per MDLN's latest filing, from $961.0 million in the prior quarter.
• Across five years, Accounts Payables topped out at $961.0 million in Q4 2025 and bottomed at $869.0 million in Q4 2024.
• The 3-year median for Accounts Payables is $932.0 million (2026), against an average of $920.7 million.
• Peak annual rise in Accounts Payables reached 10.59% in 2025, while the deepest fall reached 10.59% in 2025.
• Tracing MDLN's Accounts Payables over 3 years: stood at $869.0 million in 2024, then gained by 10.59% to $961.0 million in 2025, then slipped by 3.02% to $932.0 million in 2026.
• Per Business Quant, the three latest MDLN Accounts Payables figures stand at $932.0 million (Q1 2026), $961.0 million (Q4 2025), and $869.0 million (Q4 2024).

Peer Comparison